Opus Genetics, Inc. Accrued Liabilities
Opus Genetics, Inc. (IRD) had Accrued Liabilities of $287.30 thousand as of 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities › Accrued Liabilities
us-gaap:AccruedLiabilitiesCurrentAndNoncurrent · last filed 2020-10-29
- 2020-09-30: Accrued Liabilities $287.30K.
- 2020-06-30: Accrued Liabilities $454.85K.
- 2020-03-31: Accrued Liabilities $165.93K.
- 2019-12-31: Accrued Liabilities $471.70K.
| Period end | Accrued Liabilities |
|---|---|
| 2020-09-30 | $287.30K 10-Q · filed 2020-10-29 |
| 2020-06-30 | $454.85K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $165.93K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $471.70K 10-Q · filed 2020-10-29 |
| 2019-09-30 | $95.85K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $89.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $202.07K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $140.64K 10-K · filed 2020-02-21 |
| 2018-09-30 | $103.00K 10-Q · filed 2018-11-02 |
| 2018-06-30 | $162.00K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $53.38K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $95.42K 10-K · filed 2019-03-07 |
| 2017-09-30 | $142.27K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $167.30K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $34.70K 10-Q · filed 2017-05-03 |
| 2016-12-31 | $141.19K 10-K · filed 2018-03-09 |
| 2016-09-30 | $107.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $64.14K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $125.72K 10-Q · filed 2016-05-06 |
| 2015-12-31 | $92.75K 10-K · filed 2017-02-24 |
| 2015-09-30 | $166.40K 10-Q · filed 2015-11-02 |
| 2015-06-30 | $119.64K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $294.69K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $56.88K 10-K · filed 2016-03-14 |
| 2014-09-30 | $49.13K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $93.26K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $88.96K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $25.37K 10-K · filed 2015-03-16 |
| 2013-09-30 | $21.69K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $70.49K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $79.36K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $76.29K 10-K · filed 2014-03-21 |
| 2012-09-30 | $37.70K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $29.49K 10-Q · filed 2012-08-08 |
| 2011-12-31 | $50.40K 10-K · filed 2013-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |